Marker Therapeutics, Inc. (MRKR) › EPS (Diluted)Marker Therapeutics, Inc. (MRKR) — EPS (Diluted)Annual figures by period end, from SEC filings.2015-12-31: $-9.302016-12-31: $-0.722017-12-31: $-1.162020-12-31: $-0.612021-12-31: $-5.472022-12-31: $-3.582023-12-31: $-0.942024-12-31: $-1.192025-12-31: $-0.79$-0.792015-12-31EPS (Diluted) (USD/shares)2025-12-31Period endedEPS (Diluted)Change YoYSource filing2025-12-31$-0.79—2026-03-18From 2025-01-012024-12-31$-1.19—2026-03-18From 2024-01-012023-12-31$-0.94—2025-03-31From 2023-01-012022-12-31$-3.58—2024-03-26From 2022-01-012021-12-31$-5.47—2023-03-22From 2021-01-012020-12-31$-0.61—2022-03-17From 2020-01-012017-12-31$-1.16—2018-03-23From 2017-01-012016-12-31$-0.72—2018-03-23From 2016-01-012015-12-31$-9.30—2017-03-14From 2015-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)